Cottel D - Search Results

1

VLDL receptor polymorphism, cognitive impairment, and dementia.

Helbecque N, Berr C, Cottel D, Fromentin-David I, Sazdovitch V, Ricolfi F, Ducimetière P, Di Menza C, Amouyel P. Helbecque N, et al. Among authors: cottel d. Neurology. 2001 May 8;56(9):1183-8. doi: 10.1212/wnl.56.9.1183. Neurology. 2001. PMID: 11342683

2

The role of matrix metalloproteinase-9 in dementia.

Helbecque N, Hermant X, Cottel D, Amouyel P. Helbecque N, et al. Among authors: cottel d. Neurosci Lett. 2003 Oct 30;350(3):181-3. doi: 10.1016/s0304-3940(03)00905-4. Neurosci Lett. 2003. PMID: 14550924

3

Paraoxonase 1 gene polymorphisms and dementia in humans.

Helbecque N, Cottel D, Codron V, Berr C, Amouyel P. Helbecque N, et al. Among authors: cottel d. Neurosci Lett. 2004 Mar 18;358(1):41-4. doi: 10.1016/j.neulet.2003.12.100. Neurosci Lett. 2004. PMID: 15016430

4

APOE promoter polymorphisms and dementia in the elderly.

Lambert JC, Berr C, Cottel D, Amouyel P, Helbecque N. Lambert JC, et al. Among authors: cottel d. Neurosci Lett. 2004 Jul 22;365(2):116-9. doi: 10.1016/j.neulet.2004.04.063. Neurosci Lett. 2004. PMID: 15245790

5

Low-density lipoprotein receptor-related protein 8 gene polymorphisms and dementia.

Helbecque N, Cottel D, Amouyel P. Helbecque N, et al. Among authors: cottel d. Neurobiol Aging. 2009 Feb;30(2):266-71. doi: 10.1016/j.neurobiolaging.2007.05.024. Epub 2007 Jul 5. Neurobiol Aging. 2009. PMID: 17614163

6

An apolipoprotein A-I gene promoter polymorphism associated with cognitive decline, but not with Alzheimer's disease.

Helbecque N, Codron V, Cottel D, Amouyel P. Helbecque N, et al. Among authors: cottel d. Dement Geriatr Cogn Disord. 2008;25(2):97-102. doi: 10.1159/000112176. Epub 2007 Dec 10. Dement Geriatr Cogn Disord. 2008. PMID: 18073484

7

The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment.

Amouyel P, Richard F, Cottel D, Amant C, Codron V, Helbecque N. Amouyel P, et al. Among authors: cottel d. Neurosci Lett. 1996 Oct 18;217(2-3):203-5. Neurosci Lett. 1996. PMID: 8916108 Clinical Trial.

8

The very low density lipoprotein (VLDL) receptor is a genetic susceptibility factor for Alzheimer disease in a European Caucasian population.

Helbecque N, Richard F, Cottel D, Neuman E, Guez D, Amouyel P. Helbecque N, et al. Among authors: cottel d. Alzheimer Dis Assoc Disord. 1998 Dec;12(4):368-71. doi: 10.1097/00002093-199812000-00019. Alzheimer Dis Assoc Disord. 1998. PMID: 9876967

9

A functional polymorphism in a STAT5B site of the human PPAR gamma 3 gene promoter affects height and lipid metabolism in a French population.

Meirhaeghe A, Fajas L, Gouilleux F, Cottel D, Helbecque N, Auwerx J, Amouyel P. Meirhaeghe A, et al. Among authors: cottel d. Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):289-94. doi: 10.1161/01.atv.0000051382.28752.fe. Arterioscler Thromb Vasc Biol. 2003. PMID: 12588773

10

The Gly16-->Arg16 and Gln27-->Glu27 polymorphisms of beta2-adrenergic receptor are associated with metabolic syndrome in men.

Dallongeville J, Helbecque N, Cottel D, Amouyel P, Meirhaeghe A. Dallongeville J, et al. Among authors: cottel d. J Clin Endocrinol Metab. 2003 Oct;88(10):4862-6. doi: 10.1210/jc.2003-030173. J Clin Endocrinol Metab. 2003. PMID: 14557466

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters